State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
出版年份 2023 全文链接
标题
State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
作者
关键词
-
出版物
Research and Reports in Tropical Medicine
Volume Volume 14, Issue -, Pages 1-19
出版商
Informa UK Limited
发表日期
2023-06-14
DOI
10.2147/rrtm.s415273
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
- (2023) Cristina Vázquez et al. Revista da Sociedade Brasileira de Medicina Tropical
- 3Rs Principle and Legislative Decrees to Achieve High Standard of Animal Research
- (2023) Paolo Verderio et al. Animals
- Impact of Laboratory-Adapted Intracellular Trypanosoma cruzi Strains on the Activity Profiles of Compounds with Anti-T. cruzi Activity
- (2023) Melissa L. Sykes et al. Microorganisms
- The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
- (2022) Roberto Rodrigues Ferreira et al. Frontiers in Cellular and Infection Microbiology
- Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection
- (2022) Juliana Magalhães Chaves Barbosa et al. Microbiology Spectrum
- Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy
- (2022) Elizabeth L. Malcolm et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- ColabFold: making protein folding accessible to all
- (2022) Milot Mirdita et al. NATURE METHODS
- A phase-2, randomized, multicenter, placebo-controlled, proof-of-concept trial of oral fexinidazole in adults with chronic indeterminate Chagas disease
- (2022) Faustino Torrico et al. CLINICAL INFECTIOUS DISEASES
- The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi
- (2022) Albert Ros-Lucas et al. Frontiers in Cellular and Infection Microbiology
- Diffuse Myocardial Fibrosis and Cardiomyocyte Diameter Are Associated With Heart Failure Symptoms in Chagas Cardiomyopathy
- (2022) Cristiane Nardi Gemme et al. Frontiers in Cardiovascular Medicine
- Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway
- (2022) Joanna Panecka-Hofman et al. Expert Opinion on Drug Discovery
- Benchmarking AlphaFold ‐enabled molecular docking predictions for antibiotic discovery
- (2022) Felix Wong et al. Molecular Systems Biology
- Anti-trypanosomatid drug discovery: progress and challenges
- (2022) Manu De Rycker et al. NATURE REVIEWS MICROBIOLOGY
- Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
- (2022) Amanda Fortes Francisco et al. PLoS Neglected Tropical Diseases
- Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates
- (2022) Angel M. Padilla et al. Nature Microbiology
- Animal Models of Trypanosoma cruzi Congenital Transmission
- (2022) Eduardo E. Avalos-Borges et al. Pathogens
- Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
- (2022) Victor Kande Betu Kumeso et al. LANCET INFECTIOUS DISEASES
- The impact of AlphaFold Protein Structure Database on the fields of life sciences
- (2022) Mihaly Varadi et al. PROTEOMICS
- Novel machine learning approaches revolutionize protein knowledge
- (2022) Nicola Bordin et al. TRENDS IN BIOCHEMICAL SCIENCES
- Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds
- (2021) Nieves Martinez-Peinado et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival
- (2021) N. Baker et al. Nature Communications
- Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi
- (2021) Carlos Talavera-López et al. Frontiers in Cellular and Infection Microbiology
- Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
- (2021) Marie-José Bijlmakers Frontiers in Chemistry
- New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
- (2021) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis
- (2021) Andrea Vela et al. PLoS Neglected Tropical Diseases
- An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
- (2021) Violeta Kourbeli et al. MOLECULES
- Highly accurate protein structure prediction with AlphaFold
- (2021) John Jumper et al. NATURE
- Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease
- (2021) Nieves Martínez-Peinado et al. Parasites & Vectors
- Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box
- (2021) Juan Cantizani et al. PLoS Neglected Tropical Diseases
- Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale
- (2021) Archie A. Khan et al. PLoS Pathogens
- From Magic Bullet to Magic Bomb: Reductive Bioactivation of Antiparasitic Agents
- (2021) Sergio Wittlin et al. ACS Infectious Diseases
- Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi
- (2021) Nieves Martinez-Peinado et al. Pharmaceuticals
- Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas’ Disease
- (2021) Marta L. Lima et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
- (2021) Charles E. Mowbray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against Trypanosoma cruzi
- (2021) Lorraine Martins Rocha Orlando et al. MOLECULES
- AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
- (2021) Mihaly Varadi et al. NUCLEIC ACIDS RESEARCH
- VEuPathDB: the eukaryotic pathogen, vector and host bioinformatics resource center
- (2021) Beatrice Amos et al. NUCLEIC ACIDS RESEARCH
- A resource for improved predictions of Trypanosoma and Leishmania protein three-dimensional structure
- (2021) Richard John Wheeler PLoS One
- Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay
- (2021) Nina Svensen et al. PLoS Neglected Tropical Diseases
- Drug Target Validation of the Protein Kinase AEK1, Essential for Proliferation, Host Cell Invasion, and Intracellular Replication of the Human Pathogen Trypanosoma cruzi
- (2021) Miguel A. Chiurillo et al. Microbiology Spectrum
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
- (2020) Olivier J. Wouters et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Computational approaches for drug discovery against trypanosomatid-caused diseases
- (2020) Claudio A. Pereira et al. PARASITOLOGY
- A CRISPR/Cas9-riboswitch-Based Method for Downregulation of Gene Expression in Trypanosoma cruzi
- (2020) Noelia Lander et al. Frontiers in Cellular and Infection Microbiology
- Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control
- (2020) Augusto E. Bivona et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- C57BL/6 α-1,3-Galactosyltransferase Knockout Mouse as an Animal Model for Experimental Chagas Disease
- (2020) Edward Valencia Ayala et al. ACS Infectious Diseases
- Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling
- (2020) Alfredo Juárez-Saldivar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases
- (2020) Advait Nagle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of Posaconazole in an in vitro model of cardiac fibrosis induced by Trypanosoma cruzi
- (2020) Lindice Mitie Nisimura et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Challenges in Chagas Disease Drug Development
- (2020) Amanda F. Francisco et al. MOLECULES
- Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
- (2020) Nieves Martinez-Peinado et al. Parasites & Vectors
- In Vivo Analysis of Trypanosoma cruzi Persistence Foci at Single-Cell Resolution
- (2020) Alexander I. Ward et al. mBio
- Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
- (2020) Izumi V. Hinkson et al. Frontiers in Pharmacology
- Animal models of Chagas disease and their translational value to drug development
- (2020) Eric Chatelain et al. Expert Opinion on Drug Discovery
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Theo Vos et al. LANCET
- Host‐parasite dynamics in Chagas disease from systemic to hyper‐local scales
- (2020) Damián Pérez‐Mazliah et al. PARASITE IMMUNOLOGY
- Trypanosoma Cruzi Genome: Organization, Multi-Gene Families, Transcription, and Biological Implications
- (2020) Alfonso Herreros-Cabello et al. Genes
- Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge
- (2020) Javier Martín-Escolano et al. ACS Infectious Diseases
- Dogs as a model for chemotherapy of Chagas disease and Leishmaniasis
- (2020) Marta de Lana et al. CURRENT PHARMACEUTICAL DESIGN
- In Silico Identification of New Targets for Diagnosis, Vaccine, and Drug Candidates against Trypanosoma cruzi
- (2020) Rafael Obata Trevisan et al. DISEASE MARKERS
- Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease
- (2019) Juan Felipe Osorio-Méndez et al. Frontiers in Cellular and Infection Microbiology
- American Trypanosomiasis (Chagas Disease)
- (2019) Luis E. Echeverria et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Chemical Constituents of Anacardium occidentale as Inhibitors of Trypanosoma cruzi Sirtuins
- (2019) Tanira Matutino Bastos et al. MOLECULES
- Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
- (2019) Susan Wyllie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease
- (2019) Irene Roquero et al. International Journal for Parasitology-Drugs and Drug Resistance
- State‐of‐the‐art CRISPR /Cas9 Technology for Genome Editing in Trypanosomatids
- (2019) Noelia Lander et al. JOURNAL OF EUKARYOTIC MICROBIOLOGY
- TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
- (2019) Roberto Rodrigues Ferreira et al. PLoS Neglected Tropical Diseases
- An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of Trypanosoma cruzi That Depicts the Multifunctionality and Dysfunctionality of T Cells
- (2019) Jose Mateus et al. Frontiers in Immunology
- Investigation of a combination of amiodarone and itraconazole for treatment of American trypanosomiasis (Chagas disease) in dogs
- (2019) Roy Madigan et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- Protozoan persister-like cells and drug treatment failure
- (2019) Michael P. Barrett et al. NATURE REVIEWS MICROBIOLOGY
- Why hasn’t there been more progress in new Chagas disease drug discovery?
- (2019) Alane Beatriz Vermelho et al. Expert Opinion on Drug Discovery
- In vitro models for investigation of the host-parasite interface - possible applications in acute Chagas disease
- (2019) Natália Martins Breyner et al. ACTA TROPICA
- Chagas Disease: Chronic Chagas Cardiomyopathy
- (2019) Natalia Giraldo Echavarría et al. CURRENT PROBLEMS IN CARDIOLOGY
- In silico repositioning of etidronate as a potential inhibitor of the Trypanosoma cruzi enolase
- (2019) Edward A. Valera-Vera et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Assessing the effectiveness of curative benznidazole treatment in preventing chronic cardiac pathology in experimental models of Chagas disease
- (2018) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- TGF-β Polymorphisms Are a Risk Factor for Chagas Disease
- (2018) Roberto Rodrigues Ferreira et al. DISEASE MARKERS
- Chagas disease
- (2018) José A Pérez-Molina et al. LANCET
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
- (2018) Lorna M. MacLean et al. PLoS Neglected Tropical Diseases
- Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping
- (2018) Fernanda Cristina Costa et al. PLoS Neglected Tropical Diseases
- Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
- (2018) Fernando J Sánchez-Valdéz et al. eLife
- Innovation in neglected tropical disease drug discovery and development
- (2018) Hong-Bo Weng et al. Infectious Diseases of Poverty
- A Magnetic Resonance Imaging Study of Intestinal Dilation in Trypanosoma cruzi–infected Mice Deficient in Nitric Oxide Synthase
- (2018) Lars Ny et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The potent ITK/BTK inhibitor Ibrutinib is effective for the treatment of experimental visceral leishmaniasis caused by Leishmania donovani
- (2018) Sanjay Varikuti et al. JOURNAL OF INFECTIOUS DISEASES
- Imaging the development of chronic Chagas disease after oral transmission
- (2018) Michael D. Lewis et al. Scientific Reports
- Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis
- (2018) Cinara Stein et al. PLoS Neglected Tropical Diseases
- Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study
- (2018) Daiane Dias Ferreira et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites
- (2018) Sanjay Varikuti et al. Frontiers in Microbiology
- Synthesis and antitrypanosomal activities of novel pyridylchalcones
- (2017) Avninder S. Bhambra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phenotypic screening approaches for Chagas disease drug discovery
- (2017) Eric Chatelain et al. Expert Opinion on Drug Discovery
- Nonhuman Primates and Translational Research—Cardiovascular Disease
- (2017) Laura A Cox et al. ILAR JOURNAL
- In silico identification of inhibitors of ribose 5-phosphate isomerase from Trypanosoma cruzi using ligand and structure based approaches
- (2017) Vanessa de V. C. Sinatti et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Beneficial immunomodulatory and neuro digestive effect in Trypanosoma cruzi infection after Lycopodium clavatum 13c treatment
- (2017) Camila Fernanda Brustolin Aleixo et al. MICROBIAL PATHOGENESIS
- Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease
- (2017) Danielle Marquete Vitelli-Avelar et al. PLoS Neglected Tropical Diseases
- Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection
- (2017) A. Trey Belew et al. PLoS Pathogens
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
- (2017) Antoine Daina et al. Scientific Reports
- Rapid Chagas Disease Drug Target Discovery Using Directed Evolution in Drug-Sensitive Yeast
- (2016) Sabine Ottilie et al. ACS Chemical Biology
- Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease
- (2016) Roberto Rodrigues Ferreira et al. IMMUNOBIOLOGY
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade
- (2016) Manu De Rycker et al. PLoS Neglected Tropical Diseases
- Here, There, and Everywhere: The Ubiquitous Distribution of the Immunosignaling Molecule Lysophosphatidylcholine and Its Role on Chagas Disease
- (2016) Mário Alberto C. Silva-Neto et al. Frontiers in Immunology
- Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly SensitiveIn VivoImaging
- (2015) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents
- (2015) César Mendoza-Martínez et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Translational challenges of animal models in Chagas disease drug development: a review
- (2015) Eric Chatelain et al. Drug Design Development and Therapy
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- (2015) Jennifer Riley et al. PLoS Neglected Tropical Diseases
- Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
- (2015) Julio Alonso-Padilla et al. PLoS Neglected Tropical Diseases
- HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics
- (2014) Jong Min Choi et al. ARCHIVES OF PHARMACAL RESEARCH
- Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
- (2014) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
- (2014) Bianca Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
- (2014) Israel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives
- (2014) Juan Carlos Villalobos-Rocha et al. PARASITOLOGY RESEARCH
- Structural and Functional Analysis of a Platelet-Activating Lysophosphatidylcholine of Trypanosoma cruzi
- (2014) Felipe Gazos-Lopes et al. PLoS Neglected Tropical Diseases
- High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
- (2014) Julio Alonso-Padilla et al. PLoS Neglected Tropical Diseases
- Regulators of Trypanosoma brucei Cell Cycle Progression and Differentiation Identified Using a Kinome-Wide RNAi Screen
- (2014) Nathaniel G. Jones et al. PLoS Pathogens
- Approaches to Protozoan Drug Discovery: Phenotypic Screening
- (2013) Melissa L. Sykes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Use of clomipramine as chemotherapy of the chronic phase of Chagas disease
- (2013) ROMINA FAURO et al. PARASITOLOGY
- Improved Completion Rates and Characterization of Drug Reactions with an Intensive Chagas Disease Treatment Program in Rural Bolivia
- (2013) Jeffrey A. Tornheim et al. PLoS Neglected Tropical Diseases
- Bisphosphonate metal complexes as selective inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase
- (2012) Bruno Demoro et al. DALTON TRANSACTIONS
- Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains
- (2012) Sabrina Cencig et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cardiomyopathy prognosis after benznidazole treatment in chronic canine Chagas' disease
- (2012) F. M. Santos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The emerging role of amiodarone and dronedarone in Chagas disease
- (2012) Gustavo Benaim et al. Nature Reviews Cardiology
- Fexinidazole: A Potential New Drug Candidate for Chagas Disease
- (2012) Maria Terezinha Bahia et al. PLoS Neglected Tropical Diseases
- Identification of small-molecule inhibitors of Trypansoma cruzi replication
- (2011) Andrew R. Germain et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Shotgun Sequencing Analysis of Trypanosoma cruzi I Sylvio X10/1 and Comparison with T. cruzi VI CL Brener
- (2011) Oscar Franzén et al. PLoS Neglected Tropical Diseases
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ECG Detection of Murine Chagasic Cardiomyopathy
- (2010) Christopher S. Eickhoff et al. JOURNAL OF PARASITOLOGY
- Chagas disease and stroke
- (2010) Francisco Javier Carod-Artal et al. LANCET NEUROLOGY
- In vitro and in vivo experimental models for drug screening and development for Chagas disease
- (2010) Alvaro José Romanha et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- High-content imaging for automated determination of host-cell infection rate by the intracellular parasite Trypanosoma cruzi
- (2010) L.L. Nohara et al. PARASITOLOGY INTERNATIONAL
- In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
- (2010) Adriana M. C. Canavaci et al. PLoS Neglected Tropical Diseases
- Coronary Microvascular Disease in Chronic Chagas Cardiomyopathy Including an Overview on History, Pathology, and Other Proposed Pathogenic Mechanisms
- (2010) Marcos A. Rossi et al. PLoS Neglected Tropical Diseases
- Retention and Loss of RNA Interference Pathways in Trypanosomatid Protozoans
- (2010) Lon-Fye Lye et al. PLoS Pathogens
- Chagas disease in Spain, the United States and other non-endemic countries
- (2009) Joaquim Gascon et al. ACTA TROPICA
- TriTrypDB: a functional genomic resource for the Trypanosomatidae
- (2009) Martin Aslett et al. NUCLEIC ACIDS RESEARCH
- Identification of Three Classes of Heteroaromatic Compounds with Activity against Intracellular Trypanosoma cruzi by Chemical Library Screening
- (2009) Esther Bettiol et al. PLoS Neglected Tropical Diseases
- Fibrosis and Hypertrophy Induced byTrypanosoma cruziin a Three‐Dimensional Cardiomyocyte‐Culture System
- (2008) Luciana Ribeiro Garzoni et al. JOURNAL OF INFECTIOUS DISEASES
- Natural Chagas disease in four baboons
- (2008) Jeff T. Williams et al. JOURNAL OF MEDICAL PRIMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search